CardioVascular and Interventional Radiology

, Volume 22, Issue 6, pp 481–485 | Cite as

Complications following balloon-occluded arterial infusion chemotherapy for pelvic malignancies

  • Koji Sugimoto
  • Shozo Hirota
  • Kazufumi Imanaka
  • Tetsuya Kawabe
  • Yoshiharu Nakayama
  • Yasuhito Takeuchi
Clinical Investigations


Purpose: To evaluate the incidence and causes of complications associated with balloon-occluded arterial infusion chemotherapy (BOAI) for pelvic malignancies.

Methods: In 34 courses of BOAI in 22 patients with pelvic malignancies, we analyzed the incidence of complications as well as the effect of the dose of the anticancer drugs, the infusion site, and the number of BOAI administrations on these complications. Complications were divided into two categories: cystitis-like symptoms and neurological complications such as pain, numbness, and paresthesia of the lower extremities and the hip.

Results: Eleven patients (50%) suffered from complications, seven (31.8%) from neurological complications and four (18.2%) from cystitis-like symptoms. The complications appeared in 14 courses (42.4%) of BOAI, neurological complications in 10 (30.3%) and cystitis-like symptoms in four (12.1%). A high dose of anti-cancer drugs and infusion from the anterior division tended to induce neurological complications more frequently; however, the cystitis-like symptoms were not related to any factors.

Conclusion: Our results indicate that a smaller dose of anticancer drugs should be infused from the bilateral internal iliac arteries for safer pelvic BOAI.

Key words

Balloon-occluded arterial infusion chemotherapy Pelvic malignancies Anticancer drugs Complication 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Morita S, Takemura T, Matsumoto S, Odani R (1989) Neurologic complications following intraarterial chemoinfusion and/or chemoembolization of pelvic malignancies. Nippon Acta Radiol 49:742–747PubMedGoogle Scholar
  2. 2.
    Yamada R, Yamaguchi S, Nakatsuka H, Nakamura K, Sato M, Kabayashi N, Takashima S, Sangen H (1981) Balloon-occluded arterial infusion: A new method for administration of anticancer drugs. Nippon Acta Radiol 41:894–896PubMedGoogle Scholar
  3. 3.
    Sawada T, Yoshimura Y, Kawakami S (1994) Balloon occluded arterial infusion (BOAI) treatment of patients with locally advanced cervical carcinoma. Anticancer Res 14:2791–2794PubMedGoogle Scholar
  4. 4.
    Yamashita Y, Takahashi M, Bussaka H, Korogi Y, Saito R, Miyazaki K, Fujisaki S, Okamura H (1989) Balloon-occluded arterial infusion therapy in the treatment of primary and recurrent gynecologic malignancies. Cardiovasc Intervent Radiol 12:188–195PubMedCrossRefGoogle Scholar
  5. 5.
    Tsuji K, Yamada R, Kawabata M, Mitsuzane K, Sato M, Iwahashi M, Kitayama S, Nakano R (1995) Effect of balloon-occluded arterial infusion of anticancer drugs on the prognosis of cervical cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 32:1337–1345PubMedGoogle Scholar
  6. 6.
    Andoh K, Odagiri K, Kitamura T, Yamashita K, Doiuchi T, Kinoshita T, Senoo K (1998) Balloon-occluded arterial infusion chemotherapy in treatment of the patients with locally recurrent carcinoma of the cervix who previously received radiation therapy. Nippon Acta Radiol 58:1–6PubMedGoogle Scholar
  7. 7.
    Arima K, Tochigi H, Sugimura Y, Kawamura J (1997) Balloon-occluded arterial infusion as a useful neoadjuvant chemotherapy for bladder cancer. Br J Urol 80:417–420PubMedGoogle Scholar
  8. 8.
    Patt YZ, Peters RE, Chung VP, Wallace S, Claghorn L, Mavligit G (1985) Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycin. Cancer 56:2175–2180PubMedCrossRefGoogle Scholar
  9. 9.
    Kawagoe K, Iijima S, Sasaki J (1983) Recurrent cervical cancer in the pelvis. Jpn J Clin Oncol 13:673–681PubMedGoogle Scholar
  10. 10.
    Morris M, Eifel PJ, Bruke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM (1995) Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynacol Oncol 57:72–78CrossRefGoogle Scholar
  11. 11.
    Yamada T, Ohsugi F, Irie T, Ishii C, Sadaoka S, Tada S (1996) Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alternation of intrapelvic blood flow and implantation of a vascular access device. Cardiovasc Intervent Radiol 19:139–145PubMedCrossRefGoogle Scholar
  12. 12.
    Kawabata M (1988) Development of balloon-occluded arterial infusion (BOAI) and its clinical application in hepatocellular carcinoma. J Jpn Soc Cancer Ther 23:1740–1751Google Scholar
  13. 13.
    Ueda E, Sako M, Hirota S (1992) Experimental and clinical study of arterial damage induced by anti-cancer drug infusion. Nippon Acta Radiol 52:960–970PubMedGoogle Scholar
  14. 14.
    Nagayama T (1970) A study on the treatment of bladder cancer. I. Basic study on the continuous infusion into internal iliac artery for bladder cancer. Jpn J Urol 61:271–283Google Scholar
  15. 15.
    Hollinshead WH (1971) Thorax, abdomen, and pelvis. In: Anatomy for Surgeons, vol. 12. Harper and Row, New York, pp 665–6733Google Scholar
  16. 16.
    Sugai Y, Hosoya T, Yamaguchi K, Kubota Y (1992) Hemodynamics in the territory of balloon-occluded internal iliac artery: Problems of balloon-occluded arterial infusion therapy for urinary bladder cancer. Nippon Acta Radiol 52:1258–1272PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1999

Authors and Affiliations

  • Koji Sugimoto
    • 1
  • Shozo Hirota
    • 2
  • Kazufumi Imanaka
    • 1
  • Tetsuya Kawabe
    • 1
  • Yoshiharu Nakayama
    • 3
  • Yasuhito Takeuchi
    • 4
  1. 1.Department of RadiologyNishi-Kobe Medical CenterKobeJapan
  2. 2.School of MedicineCentral Radiological Division, Kobe UniversityKobeJapan
  3. 3.Department of UrologyNishi-Kobe Medical CenterKobeJapan
  4. 4.Department of Gynecology and ObstetricsNishi-Kobe Medical CenterKobeJapan

Personalised recommendations